logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Davies, Michael John, Dr
    Born in March 1962
    Individual (11 offsprings)
    Officer
    icon of calendar 2016-11-08 ~ now
    OF - Director → CIF 0
    Dr Michael John Davies
    Born in March 1962
    Individual (11 offsprings)
    Person with significant control
    icon of calendar 2016-11-08 ~ now
    PE - Right to appoint or remove directors with control over the trustees of a trustCIF 0
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
    PE - Has significant influence or control as a member of a firmCIF 0
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
    PE - Ownership of shares – More than 50% but less than 75% as a member of a firmCIF 0
    PE - Right to appoint or remove directors as a member of a firmCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% as a member of a firmCIF 0
    PE - Has significant influence or control over the trustees of a trustCIF 0
  • 2
    AIRMED LIMITED - 2023-06-02
    icon of addressDeepbridge House Honeycomb East, Chester Business Park, Chester, United Kingdom
    Active Corporate (2 parents, 21 offsprings)
    Equity (Company account)
    -103 GBP2024-01-31
    Officer
    icon of calendar 2024-09-13 ~ now
    OF - Director → CIF 0
Ceased 1
  • Dr Michael John Davies
    Born in March 1962
    Individual (11 offsprings)
    Person with significant control
    icon of calendar 2016-11-08 ~ 2018-07-04
    PE - Right to appoint or remove directors with control over the trustees of a trustCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Right to appoint or remove directors as a member of a firmCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
parent relation
Company in focus

CAROCELL BIO LIMITED

Previous names
BRIDGE BIOTEC THERAPEUTICS LIMITED - 2017-02-20
BRIDGE BIOTECH THERAPEUTICS LIMITED - 2016-11-15
BRIDGE BIOTEC LIMITED - 2019-08-14
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
75000 - Veterinary Activities
86900 - Other Human Health Activities
Brief company account
Intangible Assets
18,352 GBP2024-11-30
13,957 GBP2023-11-30
Property, Plant & Equipment
283 GBP2024-11-30
928 GBP2023-11-30
Fixed Assets
18,635 GBP2024-11-30
14,885 GBP2023-11-30
Debtors
Current
8,212 GBP2024-11-30
6,882 GBP2023-11-30
Cash at bank and in hand
854 GBP2024-11-30
6,931 GBP2023-11-30
Current Assets
9,066 GBP2024-11-30
13,813 GBP2023-11-30
Net Current Assets/Liabilities
-4,453 GBP2024-11-30
4,853 GBP2023-11-30
Total Assets Less Current Liabilities
14,182 GBP2024-11-30
19,738 GBP2023-11-30
Net Assets/Liabilities
-367,205 GBP2024-11-30
-340,231 GBP2023-11-30
Equity
Called up share capital
1,234 GBP2024-11-30
1,215 GBP2023-11-30
Share premium
814,895 GBP2024-11-30
744,262 GBP2023-11-30
Retained earnings (accumulated losses)
-1,183,334 GBP2024-11-30
-1,085,708 GBP2023-11-30
Equity
-367,205 GBP2024-11-30
-340,231 GBP2023-11-30
Average Number of Employees
22023-12-01 ~ 2024-11-30
42022-12-01 ~ 2023-11-30
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
39,219 GBP2024-11-30
30,903 GBP2023-11-30
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
20,867 GBP2024-11-30
16,946 GBP2023-11-30
Intangible Assets - Increase From Amortisation Charge for Year
Patents/Trademarks/Licences/Concessions
3,921 GBP2023-12-01 ~ 2024-11-30
Intangible Assets
Patents/Trademarks/Licences/Concessions
18,352 GBP2024-11-30
13,957 GBP2023-11-30
Property, Plant & Equipment - Gross Cost
Tools/Equipment for furniture and fittings
6,422 GBP2024-11-30
6,089 GBP2023-11-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Tools/Equipment for furniture and fittings
6,139 GBP2024-11-30
5,161 GBP2023-11-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Tools/Equipment for furniture and fittings
978 GBP2023-12-01 ~ 2024-11-30
Property, Plant & Equipment
Tools/Equipment for furniture and fittings
283 GBP2024-11-30
928 GBP2023-11-30
Other Debtors
Amounts falling due within one year, Current
8,212 GBP2024-11-30
6,882 GBP2023-11-30
Debtors
Amounts falling due within one year, Current
8,212 GBP2024-11-30
6,882 GBP2023-11-30

  • CAROCELL BIO LIMITED
    Info
    BRIDGE BIOTEC THERAPEUTICS LIMITED - 2017-02-20
    BRIDGE BIOTECH THERAPEUTICS LIMITED - 2017-02-20
    BRIDGE BIOTEC LIMITED - 2017-02-20
    Registered number 10469714
    icon of addressLondon Bioscience Innovation Centre (lbic), 2 Royal College Street, London NW1 0NH
    PRIVATE LIMITED COMPANY incorporated on 2016-11-08 (9 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2024-11-07
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.